Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Date
2017Journal
Fertility and SterilityPublisher
Elsevier Inc.Type
Article
Metadata
Show full item recordAbstract
Objective: To identify reproductive, lifestyle, hormonal, and other correlates of circulating antimüllerian hormone (AMH) concentrations in mostly late premenopausal women. Design: Cross-sectional study. Setting: Not applicable. Patient(s): A total of 671 premenopausal women not known to have cancer. Intervention(s): None. Main Outcome Measure(s): Concentrations of AMH were measured in a single laboratory using the picoAMH ELISA. Multivariable-adjusted median (and interquartile range) AMH concentrations were calculated using quantile regression for several potential correlates. Result(s): Older women had significantly lower AMH concentrations (≥40 [n = 444] vs. <35 years [n = 64], multivariable-adjusted median 0.73 ng/mL vs. 2.52 ng/mL). Concentrations of AMH were also significantly lower among women with earlier age at menarche (<12 [n = 96] vs. ≥14 years [n = 200]: 0.90 ng/mL vs. 1.12 ng/mL) and among current users of oral contraceptives (n = 27) compared with never or former users (n = 468) (0.36 ng/mL vs. 1.15 ng/mL). Race, body mass index, education, height, smoking status, parity, and menstrual cycle phase were not significantly associated with AMH concentrations. There were no significant associations between AMH concentrations and androgen or sex hormone-binding globulin concentrations or with factors related to blood collection (e.g., sample type, time, season, and year of blood collection). Conclusion(s): Among premenopausal women, lower AMH concentrations are associated with older age, a younger age at menarche, and currently using oral contraceptives, suggesting these factors are related to a lower number or decreased secretory activity of ovarian follicles. Copyright 2017 American Society for Reproductive MedicineIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016464932&doi=10.1016%2fj.fertnstert.2017.02.105&partnerID=40&md5=9dc12ca96d8927496d5d5b2bca1800a1; http://hdl.handle.net/10713/10128ae974a485f413a2113503eed53cd6c53
10.1016/j.fertnstert.2017.02.105
Scopus Count
Collections
Related articles
- Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old).
- Authors: Marsh EE, Bernardi LA, Steinberg ML, de Chavez PJ, Visser JA, Carnethon MR, Baird DD
- Issue date: 2016 Aug
- Serum antimüllerian hormone in healthy premenopausal women.
- Authors: Shaw CM, Stanczyk FZ, Egleston BL, Kahle LL, Spittle CS, Godwin AK, Brinton LA, Dorgan JF
- Issue date: 2011 Jun 30
- Dietary factors and serum antimüllerian hormone concentrations in late premenopausal women.
- Authors: Anderson C, Mark Park YM, Stanczyk FZ, Sandler DP, Nichols HB
- Issue date: 2018 Nov
- Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study.
- Authors: Kim C, Karvonen-Gutierrez C, Kong S, Arends V, Steffes M, McConnell DS, Randolph JF Jr, Harlow SD
- Issue date: 2016 Nov
- Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study.
- Authors: Dólleman M, Verschuren WM, Eijkemans MJ, Dollé ME, Jansen EH, Broekmans FJ, van der Schouw YT
- Issue date: 2013 May